Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Tynwald backs move to bring forward business case for full Douglas Bay Horse Tramway reinstatement
FOI reveals Locate Isle of Man staff costs
Noble's Hospital is safe, insists Manx Care's medical director
Infrastructure minister defends scrapped Ramsey flood defence scheme with no alternative currently planned
